Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$244,610,864
+$59,567,070 QoQ
Shares Held
4,495,697
+4.2% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. EXEL ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $244,610,864 | 4,495,697 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $185,043,794 | 4,314,381 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $265,379,377 | 6,054,743 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $246,169,677 | 5,960,525 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $245,332,874 | 5,565,628 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $205,725,210 | 5,572,189 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $132,375,518 | 3,975,241 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,276,256 | 974,037 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $25,058,294 | 1,115,189 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $31,667,562 | 1,334,495 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $42,428,517 | 1,768,592 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $31,476,713 | 1,440,582 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $23,148,705 | 1,211,340 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,462,309 | 1,363,334 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $36,394,051 | 2,268,956 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $27,341,370 | 1,743,710 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,548,587 | 1,179,087 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,753,136 | 915,445 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,901,536 | 1,034,001 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $25,712,601 | 1,216,301 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,038,737 | 1,099,821 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $16,940,148 | 749,896 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,541,434 | 973,664 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $20,535,676 | 839,905 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,508,248 | 569,008 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $16,120,433 | 936,146 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||